Role of Monotherapy with a P2Y12 Inhibitor for Secondary Prevention in Patients with Established Atherosclerosis

被引：0
|
作者：
Juan J. Rodriguez
Luis E. Baron
Oscar C. Munoz
Jonathan J. Diaz
机构：
[1] Texas Tech University Health Sciences Center,Facultad de Medicina
[2] Universidad Autonoma de Bucaramanga,Facultad de Medicina
[3] Universidad de Boyaca,undefined
来源：
Current Cardiology Reports | 2022年 / 24卷
关键词：
Monotherapy; Antiplatelet therapy; Atherosclerosic disease; Stroke; Myocardial infarction; Peripheral arterial disease; Secondary prevention;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：87 / 91
页数：4
相关论文
共 50 条
  • [41] Aspirin versus P2Y12 inhibitor-based monotherapy after percutaneous coronary intervention
    Choudhary, Rahul
    Kumari, Vimla
    AMERICAN HEART JOURNAL, 2020, 230
  • [42] P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions
    Gragnano, Felice
    Mehran, Roxana
    Branca, Mattia
    Franzone, Anna
    Baber, Usman
    Jang, Yangsoo
    Kimura, Takeshi
    Hahn, Joo-Yong
    Zhao, Qiang
    Windecker, Stephan
    Gibson, Charles M.
    Kim, Byeong-Keuk
    Watanabe, Hirotoshi
    Bin Song, Young
    Zhu, Yunpeng
    Vranckx, Pascal
    Mehta, Shamir
    Hong, Sung-Jin
    Ando, Kenji
    Gwon, Hyeon-Cheol
    Calabro, Paolo
    Serruys, Patrick W.
    Dangas, George D.
    McFadden, Eugene P.
    Angiolillo, Dominick J.
    Heg, Dik
    Valgimigli, Marco
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (06) : 537 - 552
  • [43] P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
    McCaw, Zachary R.
    Wei, Lee-Jen
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (16): : 1607 - 1607
  • [44] P2Y12 inhibitor monotherapy is associated with superior outcomes as compared with aspirin monotherapy in chronic limb-threatening ischemia
    Khan, Sikandar Z.
    O'Brien-Irr, Monica S.
    Fakhoury, Elias
    Montross, Brittany
    Rivero, Mariel
    Dosluoglu, Hasan H.
    Harris, Linda M.
    Dryjski, Maciej L.
    JOURNAL OF VASCULAR SURGERY, 2022, 76 (04) : 1053 - 1059
  • [45] Strategies to optimize initial P2Y12 inhibitor therapy in STEMI patients
    Millhuff, Alexandra C.
    Blankenship, James C.
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2025, 71 : 43 - 49
  • [46] P2Y12 blocker monotherapy after percutaneous coronary intervention
    F. W. A. Verheugt
    P. Damman
    S. A. J. Damen
    J. J. Wykrzykowska
    E. C. I. Woelders
    R. -J. M. van Geuns
    Netherlands Heart Journal, 2021, 29 : 566 - 576
  • [47] P2Y12 Inhibitor Adherence Patterns in Patients with Acute Coronary Syndrome
    Ozaki, Aya
    Ko, Dennis T.
    Chong, Alice
    Fang, Jiming
    Austin, Peter
    Sud, Maneesh
    Jackevicius, Cynthia A.
    CIRCULATION, 2021, 144
  • [48] Trajectories of P2Y12 inhibitor adherence in patients with acute coronary syndromes
    Moon, Jungyeon
    Ozaki, Aya F.
    Chong, Alice
    Sud, Maneesh
    Fang, Jiming
    Austin, Peter C.
    Ko, Dennis T.
    Jackevicius, Cynthia A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (01)
  • [49] P2Y12 blocker monotherapy after percutaneous coronary intervention
    Verheugt, F. W. A.
    Damman, P.
    Damen, S. A. J.
    Wykrzykowska, J. J.
    Woelders, E. C. I.
    van Geuns, R. -J. M.
    NETHERLANDS HEART JOURNAL, 2021, 29 (11) : 566 - 576
  • [50] P2Y12 Inhibitor Monotherapy with Clopidogrel versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Chen, Po-Wei
    Feng, Wen-Han
    Ho, Ming-Yun
    Su, Chun-Hung
    Huang, Sheng-Wei
    Cheng, Chung-Wei
    Yeh, Hung-, I
    Chen, Ching-Pei
    Huang, Wei-Chun
    Fang, Ching-Chang
    Lin, Hui-Wen
    Lin, Sheng-Hsiang
    Hsieh, I-Chang
    Li, Yi-Heng
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06)
12345